Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Laezza

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
Trends in Pharmacological Sciences|April 23, 2013
The endocannabinoid signaling system in cancerSimona Pisanti, Paola Picardi, Alba D'Alessandro, et al.
Recent Patents on CNS Drug Discovery|July 2, 2016
Endocannabinoid System in Neurological DisordersRoberta Ranieri, Chiara Laezza, Maurizio Bifulco, et al.
Recent Patents on CNS Drug Discovery|April 22, 2016
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple SclerosisAnna M Malfitano, Chiara Laezza, Simona Pisanti, et al.
Recent Patents on CNS Drug Discovery|June 24, 2016
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune ResponseRoberta Ranieri, Chiara Laezza, Maurizio Bifulco, et al.
Molecular Carcinogenesis|July 31, 2010
Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cellsChiara Laezza, Anna M Malfitano, Tiziana Di Matola, et al.
International Journal of Molecular Sciences|March 25, 2022
Cannabinoids: Therapeutic Use in Clinical PracticeCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Journal of Cellular Physiology|December 29, 2006
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacySimona Pisanti, Cristina Borselli, Olimpia Oliviero, et al.
Expert Opinion on Therapeutic Targets|January 20, 2011
Update on the endocannabinoid system as an anticancer targetAnna Maria Malfitano, Elena Ciaglia, Giuseppina Gangemi, et al.
International Journal of Cancer|April 9, 2008
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer"Antonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, et al.
Frontiers in Pharmacology|May 13, 2022
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA MethyltransferasesMaria Chiara Proto, Donatella Fiore, Chiara Piscopo, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
Trends in Pharmacological Sciences|April 23, 2013
The endocannabinoid signaling system in cancerSimona Pisanti, Paola Picardi, Alba D'Alessandro, et al.
Recent Patents on CNS Drug Discovery|July 2, 2016
Endocannabinoid System in Neurological DisordersRoberta Ranieri, Chiara Laezza, Maurizio Bifulco, et al.
Recent Patents on CNS Drug Discovery|April 22, 2016
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple SclerosisAnna M Malfitano, Chiara Laezza, Simona Pisanti, et al.
Recent Patents on CNS Drug Discovery|June 24, 2016
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune ResponseRoberta Ranieri, Chiara Laezza, Maurizio Bifulco, et al.
Molecular Carcinogenesis|July 31, 2010
Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cellsChiara Laezza, Anna M Malfitano, Tiziana Di Matola, et al.
International Journal of Molecular Sciences|March 25, 2022
Cannabinoids: Therapeutic Use in Clinical PracticeCristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Journal of Cellular Physiology|December 29, 2006
Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacySimona Pisanti, Cristina Borselli, Olimpia Oliviero, et al.
Expert Opinion on Therapeutic Targets|January 20, 2011
Update on the endocannabinoid system as an anticancer targetAnna Maria Malfitano, Elena Ciaglia, Giuseppina Gangemi, et al.
International Journal of Cancer|April 9, 2008
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer"Antonietta Santoro, Patrizia Gazzerro, Anna Maria Malfitano, et al.
Frontiers in Pharmacology|May 13, 2022
Modified Adenosines Sensitize Glioblastoma Cells to Temozolomide by Affecting DNA MethyltransferasesMaria Chiara Proto, Donatella Fiore, Chiara Piscopo, et al.
Pageof 10